ROBLOX CORP -CLASS A (RBLX)

US7710491033 - Common Stock

61.93  +1.46 (+2.41%)

After market: 62.01 +0.08 (+0.13%)

Fundamental Rating

3

Overall RBLX gets a fundamental rating of 3 out of 10. We evaluated RBLX against 72 industry peers in the Entertainment industry. While RBLX seems to be doing ok healthwise, there are quite some concerns on its profitability. RBLX is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
RBLX had a positive operating cash flow in the past year.
In the past 5 years RBLX always reported negative net income.
In the past 5 years RBLX always reported a positive cash flow from operatings.

1.2 Ratios

RBLX has a worse Return On Assets (-15.54%) than 75.76% of its industry peers.
RBLX has a worse Return On Equity (-547.38%) than 80.30% of its industry peers.
Industry RankSector Rank
ROA -15.54%
ROE -547.38%
ROIC N/A
ROA(3y)-15.55%
ROA(5y)-13.94%
ROE(3y)-632.04%
ROE(5y)-462.51%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of RBLX (77.58%) is better than 92.42% of its industry peers.
RBLX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y-0.19%

4

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBLX has been increased compared to 1 year ago.
RBLX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RBLX has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.78 indicates that RBLX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.78, RBLX is doing good in the industry, outperforming 77.27% of the companies in the same industry.
The Debt to FCF ratio of RBLX is 1.68, which is an excellent value as it means it would take RBLX, only 1.68 years of fcf income to pay off all of its debts.
RBLX has a better Debt to FCF ratio (1.68) than 80.30% of its industry peers.
A Debt/Equity ratio of 5.30 is on the high side and indicates that RBLX has dependencies on debt financing.
RBLX has a worse Debt to Equity ratio (5.30) than 77.27% of its industry peers.
Although RBLX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF 1.68
Altman-Z 2.78
ROIC/WACCN/A
WACC9.09%

2.3 Liquidity

A Current Ratio of 0.98 indicates that RBLX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, RBLX is in line with its industry, outperforming 50.00% of the companies in the same industry.
RBLX has a Quick Ratio of 0.98. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBLX has a Quick ratio (0.98) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.02% over the past year.
Looking at the last year, RBLX shows a very strong growth in Revenue. The Revenue has grown by 27.98%.
Measured over the past years, RBLX shows a very strong growth in Revenue. The Revenue has been growing by 53.83% on average per year.
EPS 1Y (TTM)12.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.44%
Revenue 1Y (TTM)27.98%
Revenue growth 3Y44.7%
Revenue growth 5Y53.83%
Sales Q2Q%34.44%

3.2 Future

The Earnings Per Share is expected to grow by 13.38% on average over the next years. This is quite good.
RBLX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.19% yearly.
EPS Next Y14.76%
EPS Next 2Y11.19%
EPS Next 3Y10.5%
EPS Next 5Y13.38%
Revenue Next Year28.07%
Revenue Next 2Y24.19%
Revenue Next 3Y22.45%
Revenue Next 5Y17.19%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as RBLX.
Industry RankSector Rank
P/FCF 67.87
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.19%
EPS Next 3Y10.5%

0

5. Dividend

5.1 Amount

No dividends for RBLX!.
Industry RankSector Rank
Dividend Yield N/A

ROBLOX CORP -CLASS A

NYSE:RBLX (1/6/2025, 5:26:09 PM)

After market: 62.01 +0.08 (+0.13%)

61.93

+1.46 (+2.41%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners72.33%
Inst Owner Change0%
Ins Owners5.41%
Ins Owner Change-0.84%
Market Cap40.64B
Analysts78
Price Target56.6 (-8.61%)
Short Float %4.49%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.48%
Min EPS beat(2)13.59%
Max EPS beat(2)19.36%
EPS beat(4)4
Avg EPS beat(4)15.36%
Min EPS beat(4)7.73%
Max EPS beat(4)20.74%
EPS beat(8)6
Avg EPS beat(8)9.44%
EPS beat(12)6
Avg EPS beat(12)-9.47%
EPS beat(16)7
Avg EPS beat(16)-56%
Revenue beat(2)2
Avg Revenue beat(2)6.21%
Min Revenue beat(2)4.23%
Max Revenue beat(2)8.2%
Revenue beat(4)3
Avg Revenue beat(4)3.34%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)8.2%
Revenue beat(8)3
Avg Revenue beat(8)-3.32%
Revenue beat(12)3
Avg Revenue beat(12)-9.07%
Revenue beat(16)3
Avg Revenue beat(16)-15.02%
PT rev (1m)0.66%
PT rev (3m)23.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.79%
EPS NY rev (1m)0.55%
EPS NY rev (3m)3.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.11%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)3.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.08
P/FCF 67.87
P/OCF 52.03
P/B 214
P/tB 4425.53
EV/EBITDA N/A
EPS(TTM)-1.61
EYN/A
EPS(NY)-1.43
Fwd EYN/A
FCF(TTM)0.91
FCFY1.47%
OCF(TTM)1.19
OCFY1.92%
SpS5.13
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.54%
ROE -547.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.58%
FCFM 17.8%
ROA(3y)-15.55%
ROA(5y)-13.94%
ROE(3y)-632.04%
ROE(5y)-462.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF 1.68
Debt/EBITDA N/A
Cap/Depr 79.39%
Cap/Sales 5.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 2.78
F-Score6
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)207.68%
Cap/Depr(5y)237.4%
Cap/Sales(3y)12.14%
Cap/Sales(5y)13.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.44%
EPS Next Y14.76%
EPS Next 2Y11.19%
EPS Next 3Y10.5%
EPS Next 5Y13.38%
Revenue 1Y (TTM)27.98%
Revenue growth 3Y44.7%
Revenue growth 5Y53.83%
Sales Q2Q%34.44%
Revenue Next Year28.07%
Revenue Next 2Y24.19%
Revenue Next 3Y22.45%
Revenue Next 5Y17.19%
EBIT growth 1Y2.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year160.92%
EBIT Next 3Y45.87%
EBIT Next 5Y30.51%
FCF growth 1Y952.34%
FCF growth 3Y-32.94%
FCF growth 5Y28.86%
OCF growth 1Y109.81%
OCF growth 3Y-4.39%
OCF growth 5Y35.31%